Article
E2F1 as a target: promoter-driven suicide and small molecule modulators.
Cancer biology & therapy - 1 Jan 2000
Kaelin William G
Abstract excerpt
Decreased requirements for mitogens and diminished sensitivity to antiproliferative signals are among the hallmarks of human cancer. These attributes are due, at least partly, to mutations that directly or indirectly compromise the function of the retinoblastoma tumor suppressor protein (pRB), which is a negative regulator of a family of cell-cycle regulatory transcription factors referred to generically as E2F....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
